Halo Pharmaceutical, a contract development and manufacturing organization has appointed Lee Karras as its chief executive officer and Barry Lederman as its chief financial officer (CFO).
Mr. Karrashas more than 25 years of healthcare industry related experience. Prior to joining Halo, he was president of IBA Molecular North America, a manufacturer and distributor of radiopharmaceuticals. Prior to joining Halo, Mr. Lederman served as the vice rresident and CFO for Eisai Inc. with operations in the Americas region, the CFO at Wedgewood Pharmacy, Nycomed US Inc., and Qualitrol Company LLC (a subsidiary of Danaher Corporation). He also
spent 10 years with Roche in positions of increasing responsibility within finance, culminating in his appointment as senior vice president, head of business analysis and controlling at Roche Centralized Diagnostics, headquartered in Mannheim, Germany.
Halo has facilities in Whippany and East Hanover, New Jersey and Montreal, Quebec Canada. It has capabilities in a variety of dosage forms, including
tablets, capsules, powders, liquids, creams, sterile and non-sterile ointments and suppositories.
Source: Halo Pharmaceutical